[go: up one dir, main page]

EP0770094A4 - MODIFIED G PROTEIN-BINDING RECEPTORS - Google Patents

MODIFIED G PROTEIN-BINDING RECEPTORS

Info

Publication number
EP0770094A4
EP0770094A4 EP95922156A EP95922156A EP0770094A4 EP 0770094 A4 EP0770094 A4 EP 0770094A4 EP 95922156 A EP95922156 A EP 95922156A EP 95922156 A EP95922156 A EP 95922156A EP 0770094 A4 EP0770094 A4 EP 0770094A4
Authority
EP
European Patent Office
Prior art keywords
protein
modified
binding receptors
receptors
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95922156A
Other languages
German (de)
French (fr)
Other versions
EP0770094A1 (en
Inventor
Catherine D Strader
Candelore Maria-Luisa Rios
Xiaoming Guan
Richard Dixon
George Mcallister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0770094A1 publication Critical patent/EP0770094A1/en
Publication of EP0770094A4 publication Critical patent/EP0770094A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP95922156A 1994-06-29 1995-06-02 MODIFIED G PROTEIN-BINDING RECEPTORS Withdrawn EP0770094A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26798794A 1994-06-29 1994-06-29
US26814794A 1994-06-29 1994-06-29
US267987 1994-06-29
PCT/US1995/006900 WO1996000739A1 (en) 1994-06-29 1995-06-02 Modified g-protein coupled receptors
US268147 1999-03-15

Publications (2)

Publication Number Publication Date
EP0770094A1 EP0770094A1 (en) 1997-05-02
EP0770094A4 true EP0770094A4 (en) 1999-05-19

Family

ID=26952801

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95922156A Withdrawn EP0770094A4 (en) 1994-06-29 1995-06-02 MODIFIED G PROTEIN-BINDING RECEPTORS

Country Status (4)

Country Link
EP (1) EP0770094A4 (en)
JP (1) JPH10502245A (en)
CA (1) CA2193809A1 (en)
WO (1) WO1996000739A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606126D0 (en) * 1996-03-22 1996-05-22 British Biotech Pharm Biosensors
WO2000012705A2 (en) * 1998-09-01 2000-03-09 Basf Aktiengesellschaft Methods for improving the function of heterologous g protein-coupled receptors
US7094593B1 (en) 1998-09-01 2006-08-22 Basf Aktiengesellschaft Method for improving the function of heterologous G protein-coupled receptors
WO2001087976A2 (en) * 2000-05-12 2001-11-22 3-Dimensional Pharmaceuticals, Inc. Gpcr 4-helix and 5-helix bundles
EP2533046A1 (en) 2003-04-24 2012-12-12 Tyratech, Inc. Screening method for compositions for controlling insects

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001810A1 (en) * 1990-07-19 1992-02-06 Lerner Michael R Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001810A1 (en) * 1990-07-19 1992-02-06 Lerner Michael R Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JIN H. ET AL.: "Characterization of the human 5-hydroxytryptamine 1B receptor", J. BIOL. CHEM., vol. 267, no. 9, 25 March 1992 (1992-03-25), pages 5735 - 5738, XP002096624 *
See also references of WO9600739A1 *
STRADER C.D. ET AL.: "Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity.", J. BIOL. CHEM., vol. 262, no. 34, 5 December 1987 (1987-12-05), pages 16439 - 16443, XP002096623 *

Also Published As

Publication number Publication date
JPH10502245A (en) 1998-03-03
WO1996000739A1 (en) 1996-01-11
EP0770094A1 (en) 1997-05-02
CA2193809A1 (en) 1996-01-11

Similar Documents

Publication Publication Date Title
EP0791009A4 (en) MODIFIED NEUROPEPTIDE RECEPTORS
DE69635284D1 (en) NEW SUBSTITUTED NAPTHOPYRANEES
DE69635700D1 (en) NEW ENDOGLUKANASE
DE69512092D1 (en) JOINT MECHANISM
DE69536102D1 (en) NEW STREPTOGRAMINES
BR9607192A (en) Flexible tubular packaging
DE59801623D1 (en) Saddle stitcher
KR950030275U (en) Folding bicycle control
DE59504066D1 (en) HIGHLY RESISTANT MOLDED PARTS
EP0770094A4 (en) MODIFIED G PROTEIN-BINDING RECEPTORS
FIU960326U0 (en) A piston mechanism
DE69622801D1 (en) NEW CARBAPEN DERIVATIVES
EP0873409A4 (en) EQUIN RHINOVIRUS PROTEINS 1
EP0797446A4 (en) PROTEINS ASSOCIATED WITH CD40
FR2731733B1 (en) HAND PORTABLE PARPAING
FI972407A7 (en) Configuration mechanism
DE59602851D1 (en) Folding cylinder
DE69816638D1 (en) FLEXIBLE LENS
NO944204D0 (en) A choke
FIU960240U0 (en) A stop mechanism
NO962858D0 (en) Pose Binding Machine
DK23695A (en) A joint mechanism
FI945565A0 (en) A hand
KR970018515U (en) Rod material connecting mechanism
KR960036656U (en) Work stepping paper

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970129

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

RHK1 Main classification (correction)

Ipc: C12N 15/63

A4 Supplementary search report drawn up and despatched

Effective date: 19990401

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20011023

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020503